Alnylam Pharmaceuticals Inc (ALNY)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

675 WEST KENDALL STREET CAMBRIDGE, MA 02142

Operates a biopharmaceutical company seeking to develop and commercialize new drugs that work through a recently discovered system in cells known as RNA interference (RNAi). Initial programs are focused on an eye disease (macular degeneration) and lung disease (respiratory syncytial virus).

Data as of 2020-07-04
Market Cap17.208 Billion Shares Outstanding114.819 Million Avg 30-day Volume883.977 Thousand
P/E Ratio Dividend Yield EPS-8.04
Price/Sales71.672 Price cash flow ratio Price free cash flow ratio-23.9
Book Value11.76 Price to Tangible Book12.75 Alpha0.0
Short Interest Ratio % Short Interest to Float R-squared0.240757
BETA1.84742 52-week High/Low158.37 / 69.11 Stddev0.160335
View SEC Filings from ALNY instead.
Q1 2020 All Institutions Hedge Funds 1
Filers who had this stock in their top 10: 8 5 (0.33%)
13F Filers holding this stock: 314 74 (4.85%)
Aggregate 13F shares on 03/31/2020: 106.824 Million 52.306 Million
Aggregate 13F shares on 12/31/2019: 105.642 Million 54.567 Million
Percent change: 1.12% -4.14%
Funds creating new positions: 50 11
Funds Adding to an existing position: 118 29
Funds closing out their position: 33 13
Funds reducing their position: 92 27
Heat Map Ranking for 03/31/2020 110
Heat Map Ranking for 12/31/2019 54
1 hedge funds as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding ALNY (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ALNY BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

69.2 Thousand total shares from 10 transactions

Exercise Derivative Conversion (M)

69.2 Thousand total shares from 5 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

GREENSTREET YVONNE CHIEF OPERATING OFFICER

  • Officer
5,227 2020-07-09 10

GREENE BARRY E PRESIDENT

  • Officer
68,725 2020-07-07 8

SHARP PHILLIP A

  • Director
0 2020-07-01 3

FANUCCI MARSHA

  • Director
0 2020-07-01 2

AUSIELLO DENNIS A

  • Director
0 2020-07-01 1

PAUL STEVEN M

  • Director
0 2020-07-01 2

SCHULMAN AMY W

  • Director
0 2020-07-01 1

BONNEY MICHAEL W

  • Director
0 2020-07-01 1

PYOTT DAVID E I

  • Director
0 2020-07-01 1

REITAN COLLEEN F

  • Director
0 2020-07-01 1

HAMBURG MARGARET A

  • Director
0 2020-07-01 1

SATO VICKI L

  • Director
0 2020-06-25 0

VAISHNAW AKSHAY PRESIDENT, R&D

  • Officer
14,634 2020-06-22 8

SONI MANMEET SINGH

  • Director
5,902 2020-06-17 0

ALLEN PATRICIA L

  • Director
0 2020-06-10 0

STARR KEVIN P

0 2020-06-09 0

SANOFI

279,766 2020-06-09 0

MARAGANORE JOHN

  • Director
30,172 2020-05-28 8

SCHIMMEL PAUL

  • Director
495,056 2020-05-20 0

CLARKE JOHN K

  • Director
0 2020-05-06 0

KEATING LAURIE EVP, CHIEF LEGAL OFFICER

  • Officer
14,926 2020-04-20 10

BRANDICOURT OLIVIER

  • Director
0 2020-03-02 2

MASON MICHAEL SVP, CFO & TREASURER

  • Officer
0 2020-02-05 0

POULTON JEFFREY V. CHIEF FINANCIAL OFFICER

  • Officer
19 2020-01-03 2

SCHMIDT JOHN A JR

  • Director
0 2017-05-25 0

GROS DAVID-ALEXANDRE C PRESIDENT & COO

  • Officer
0 2017-02-06 0

REID LAURENCE SVP, CHIEF BUSINESS OFFICER

  • Officer
No longer subject to file 2014-12-31 0

NOVARTIS PHARMA AG

NOVARTIS AG

  • 10% Owner
No longer subject to file 2014-08-05 0

DZAU VICTOR J

18,610 2014-06-30 0

KOBLAN KENNETH S CHIEF SCIENTIFIC OFFICER

  • Officer
357 2010-12-08 0

SCOLNICK EDWARD M

  • Director
No longer subject to file 2010-07-14 0

VINCENT JAMES L

  • Director
0 2010-06-17 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

GREENSTREET YVONNE - Officer CHIEF OPERATING OFFICER

2020-07-09 S 11,236 $161.00 d 4,820 5,227.00 direct yes

GREENSTREET YVONNE - Officer CHIEF OPERATING OFFICER

2020-07-09 M 297 d 74,703 5,227.00 direct yes

GREENSTREET YVONNE - Officer CHIEF OPERATING OFFICER

2020-07-09 M 297 $77.10 a 16,056 5,227.00 direct yes

GREENSTREET YVONNE - Officer CHIEF OPERATING OFFICER

2020-07-09 M 10,939 d 3,125 5,227.00 direct yes

GREENSTREET YVONNE - Officer CHIEF OPERATING OFFICER

2020-07-09 M 10,939 $42.22 a 15,759 5,227.00 direct yes

GREENE BARRY E - Officer PRESIDENT

2020-07-07 M 22,265 d 44,530 68,725.00 direct yes

GREENE BARRY E - Officer PRESIDENT

2020-07-07 S 22,265 $159.99 d 62,236 68,725.00 direct yes

GREENE BARRY E - Officer PRESIDENT

2020-07-07 M 22,265 $9.14 a 84,501 68,725.00 direct yes

PYOTT DAVID E I - Director

2020-07-01 A 4,581 a 4,581 0.00 direct

SHARP PHILLIP A - Director

2020-07-01 A 4,581 a 4,581 0.00 direct

AUSIELLO DENNIS A - Director

2020-07-01 A 4,581 a 4,581 0.00 direct

REITAN COLLEEN F - Director

2020-07-01 A 4,581 a 4,581 0.00 direct

PAUL STEVEN M - Director

2020-07-01 A 4,581 a 4,581 0.00 direct

BONNEY MICHAEL W - Director

2020-07-01 A 4,581 a 4,581 0.00 direct

SCHULMAN AMY W - Director

2020-07-01 A 4,581 a 4,581 0.00 direct

FANUCCI MARSHA - Director

2020-07-01 A 4,581 a 4,581 0.00 direct

HAMBURG MARGARET A - Director

2020-07-01 A 4,581 a 4,581 0.00 direct

VAISHNAW AKSHAY - Officer PRESIDENT, R&D

2020-06-22 M 970 d 4,309 14,634.00 direct yes

VAISHNAW AKSHAY - Officer PRESIDENT, R&D

2020-06-22 S 180 $150.34 d 14,648 14,634.00 direct yes

VAISHNAW AKSHAY - Officer PRESIDENT, R&D

2020-06-22 M 970 $42.22 a 15,089 14,634.00 direct yes

VAISHNAW AKSHAY - Officer PRESIDENT, R&D

2020-06-22 S 195 $152.97 d 14,119 14,634.00 direct yes

VAISHNAW AKSHAY - Officer PRESIDENT, R&D

2020-06-22 S 83 $149.09 d 14,828 14,634.00 direct yes

VAISHNAW AKSHAY - Officer PRESIDENT, R&D

2020-06-22 S 334 $152.22 d 14,314 14,634.00 direct yes

VAISHNAW AKSHAY - Officer PRESIDENT, R&D

2020-06-22 S 178 $148.48 d 14,911 14,634.00 direct yes

MARAGANORE JOHN - Director - Officer CHIEF EXECUTIVE OFFICER

2020-05-20 M 34,765 $9.14 a 232,354 200,722.00 direct yes

MARAGANORE JOHN - Director - Officer CHIEF EXECUTIVE OFFICER

2020-05-20 S 16,315 $143.46 d 202,602 200,722.00 direct yes

MARAGANORE JOHN - Director - Officer CHIEF EXECUTIVE OFFICER

2020-05-20 M 34,765 d 69,530 200,722.00 direct yes

MARAGANORE JOHN - Director - Officer CHIEF EXECUTIVE OFFICER

2020-05-20 S 13,437 $142.51 d 218,917 200,722.00 direct yes

MARAGANORE JOHN - Director - Officer CHIEF EXECUTIVE OFFICER

2020-05-20 S 5,013 $144.33 d 197,589 200,722.00 direct yes
Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

Elevate your investments